Mortality in a nationwide practice-based cohort receiving paclitaxel-coated devices for lower limb peripheral artery disease

M Wargny, C Leux, G Chatellier, S Coudol… - Journal of the American …, 2024 - jacc.org
Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …
被引用次数：2 相关文章

Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease

M Wargny, C Leux, G Chatellier, S Coudol… - Journal of the American …, 2024 - Elsevier
Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …

Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease.

M Wargny, C Leux, G Chatellier, S Coudol… - Journal of the …, 2024 - europepmc.org
Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …

Mortality in a Nationwide Practice-Based Cohort Receiving Paclitaxel-Coated Devices for Lower Limb Peripheral Artery Disease

M Wargny, C Leux, G Chatellier… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Background According to a meta-analysis of randomized clinical trials, paclitaxel-coated
devices (PCDs) for lower limb endovascular revascularization may be associated with …